Word: latches
(lookup in dictionary)
(lookup stats)
Dates: during 1990-1999
Sort By: most recent first
(reverse)
...after Kerkorian's bid was made public, the company reported a 37% decline in earnings for the first three months of this year. Chrysler execs blamed high launch costs for its redesigned minivan and the $115 million expense to make free repairs on a faulty rear-door latch on older minivans--as well as a 7.2% decline in sales. Consumer Reports has grumbled about reliability problems on the 1995 Jeep Grand Cherokee and the Dodge Intrepid. And competition is getting tougher in the minivan, pickup and sport-utility fields that made Chrysler's revamped reputation. Though Eaton could still defend...
...Bradley Erwin looked like a healthy baby when he was born last March. He just didn't seem to get the hang of breast-feeding. His mother Kimberly, 38, a medical technician, tried to nurse him. "He would bob his head, root and try to latch on, but he wasn't getting anywhere," she recalls. "Everybody kept saying, 'Don't worry. Don't worry."' It was bad advice. When the infant was 12 days old, his parents rushed him to Children's Hospital in Cincinnati, Ohio. His breathing was shallow; his eyes had rolled back. "I was frantic because...
...shirtbox-size bombs, delivered by mail or private courier, were packaged in brown cardboard and wrapped with tape. Several bore the return address of an iron-and-metal company in Pennsylvania. In each was a fishing-tackle box. When the latch was opened, it connected an electrical circuit and set off several pounds of dynamite surrounded by shrapnel. One bomb killed Eleanor Fowler, 56, in West Valley, near Buffalo. Another was opened by her husband Robert, 38, at his job in an armored-car garage in nearby Cheektowaga; it killed him and a co-worker. A third blew up Lazore...
...door was locked. So I pulled out my revolver and knocked. When I heard the click of the latch, I rammed the door with my left shoulder and pushed cold steel into the guy's face...
That said, the results reported last week by New Jersey-based Bristol-Myers Squibb in the journal Science were unusually promising, and they may give new momentum to this line of research. The monoclonal antibodies used against cancer are proteins designed to latch on to a specific molecule on the surface of a tumor cell, while leaving normal cells untouched. In Bristol-Myers Squibb's experiment, the antibody was linked with the common anticancer drug doxorubicin, and unlike many previous preparations, this combination enabled the drug to enter tumor cells, killing them from the inside...